153 results
Page 5 of 8
6-K
EX-99.1
s5udwy 20fz74jg649p
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
he1tkr
25 Jul 19
Current report (foreign)
3:56pm
POS AM
wpsgx89h9rf9o9jdx
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
472nsn83h2ffq6 ddp
26 Jun 19
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
8:06am
6-K
EX-99.1
einiu8s3v40z
24 Jun 19
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
9:01am
6-K
EX-99.1
t2f 8ed27
19 Jun 19
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
8:00am
6-K
EX-99.1
vtnpldfx 0npxahjx3cj
4 Jun 19
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
vtil65j
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
EX-99.1
oipyn58pokwbip
15 May 19
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
7:56am
6-K
EX-99.1
959k8v57psimcn4b
10 May 19
Current report (foreign)
10:05am
6-K
EX-99.1
v01hdn
24 Apr 19
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
8:35am
6-K
EX-99.1
mimxhag84tsaf1q4v
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
rz8nu 6u4v2mk4
26 Mar 19
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
8:30am
6-K
EX-99.1
twwa3n
13 Mar 19
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
8:30am
6-K
EX-99.1
cwy36j0
21 Feb 19
Current report (foreign)
9:15am
6-K
EX-99.1
35aibtye4jbxydge ao
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
aqu8ew7 nw
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
2r4b1m3
14 Feb 19
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
8:05am
6-K
EX-99.1
ij8zmlthliy
14 Feb 19
Current report (foreign)
7:55am